Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.73
Delayed Data
As of 12:24pm ET
 +0.01 / +0.58%
Today’s Change
0.97
Today|||52-Week Range
2.02
-8.47%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.72
Today’s open1.74
Day’s range1.72 - 1.74
Volume198,448
Average volume (3 months)520,544
Market cap$259.3M
Dividend yield--
Data as of 12:24pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GALEGalena Biopharma Inc+0.10+6.21%
NVLSNivalis Therapeutics...+0.37+2.07%
DRNADicerna Pharmaceutic...-0.29-2.28%
PPHMPeregrine Pharmaceut...-0.03-2.34%
Data as of 12:39pm ET, 07/29/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers